FDA allows Aethlon to test Hemopurifier for HCV treatment

06/27/2013 | MedGadget.com

The FDA has granted Aethlon Medical investigational device exemption approval to conduct human feasibility trials of its Hemopurifier system, which is used in extracorporeal blood filtration procedures. The San Diego company will initially test the device in 10 end-stage renal disease patients infected with the hepatitis C virus.

View Full Article in:

MedGadget.com

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Regulatory Compliance Specialist
MJHS
Brooklyn, NY
Director of Utilization Management
Meridian Health Plan
Chicago, IL
Senior Manager, Healthcare Reform
Avalere Health
Washington, DC
Regulatory Senior Managing/Principal Engineer/Scientist
Exponent
Menlo Park, CA
Director of Claims
Meridian Health Plan
Detroit, MI